TFF Pharmaceuticals Inc., a clinical-stage biopharmaceutical company focused on developing and commercializing innovative drug products based on its patented Thin Film Freezing (TFF) technology platform, has joined forces with Cleveland Clinic to advance multiple multivalent universal influenza vaccines to protect against seasonal and pandemic viruses into preclinical testing.   The decision to advance the vaccine candidates into preclinical testing was based upon the successful completion of ...